GlaxoSmithKline Pharmaceuticals reports 23% fall in Q2 net profit

22 Oct 2018 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for second quarter ended September 30, 2018.

The company has reported a fall of 22.67% in its net profit at Rs 100.77 crore for the quarter under review as compared to Rs 130.32 crore for the same quarter in the previous year. Total income from operations of the company marginally decreased by 1.74% at Rs 831.13 crore for Q2FY19 as compared Rs 845.89 crore for the corresponding quarter previous year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×